New Survey Finds Americans Borrowed $88 Billion to Bankroll Healthcare Costs
In response to spiraling healthcare costs that continue to climb beyond what many can afford, Americans everywhere have no other choice but to grasp at alternative methods.
Did Purdue Pharma Kill 671 Massachusetts Residents? Attorney General Maura Healy Says Yes.
More than 11,000 people died from an opioid overdose in the state of Massachusetts over the last decade, and the state’s Attorney General wants to hold someone accountable. That someone is Purdue Pharma and an assortment of its most senior-ranking officials.
Lyft Picks Up Momentum in Curbing Healthcare Transportation Barriers
In a world where our roads seem more clogged than ever, it’s shocking to think that a lack of transportation can still provide a significant barrier in receiving life-sustaining goods or services. For some people, the hitch is the simple lack of a car. For others, distance is a factor. And then there’s always the costs associated with both public and private transit.
Collections Agencies Now Slapping Liens on Patients’ Homes After Unpaid Surprise Bills
It’s a sad story that we’ve unfortunately heard more times of late than we’d care to admit: the tragic tale of the consumer who did everything right only to fall victim to everything that’s wrong about the current healthcare system. We’re talking about the practice of surprise billing, also known as balance billing, and it’s starting to affect much more than just the health of Americans.
Survey: Doctors Share Interest in Drug Costs but Fail to Monitor for Adherence
While there’s plenty of evidence and feedback on how consumers feel about the price of drugs, there has been less detail made public about how physicians view these soaring costs and what they consider their role in the supply chain to be. However, a recent OptimizeRX survey that polled more than 600 providers found drug costs to be top of mind for doctors in the same way they are for consumers.
List of the Most Expensive Drugs Sees Continued Increases, New Meds Added
When it comes to most consumer goods, the flashy new items are the ones that fetch the highest dollar. Meanwhile, the price of the ordinary, decades-old models without the latest bells and whistles tend to remain relatively flat and unchanged. As an example of this pattern, you can look no further than vacuums. Unfortunately, outpatient drugs aren’t like vacuums.